Pilot Study for Azoxymethane-induced Colon Cancer in Male Wistar Rats

Riska Taufik, Abidin Pandianta, Rinaldy Kusuma, Imelda L. Winoto, Ivet Suriapranata, George Mathew

Abstract


Introduction : The use of animal models could significantly further the elucidation of Colorectal Cancer (CRC) molecular pathogenesis and help in the discovery of preventive and therapeutic agents for the disease. Dimethylhydrazine (DMH) is a widely used chemical agent for Carcinogen induced CRC model. As agent, DMH is however becoming less readily available; hence in this Pilot Study we use Azoxymethane (AOM), a DMH metabolite as an alternative agent to induce CRC in male Wistar rats.

 

Methods: Forty two male Wistar rats at six weeks of age were randomly assigned into negative control groups and groups receiving two AOM injections subcutaneously (SC) within one week interval at 15 mg/kg body weight (BW) and 20 mg/kg BW respectively. Rats were sacrificed 8, 16 and 24 weeks post- AOM administration. Aberrant crypt foci (ACF) were analyzed. Tumor foci were characterized by gross examination and histopathological characteristics.

 

Results: All rats in the AOM groups developed tumors in the colonic mucosa. Formation of ACF was detected starting from 8 weeks post-AOM injection. The highest number of ACF with multiple crypts was observed at 16 weeks post-AOM administration. The total number of ACF did not vary between the two AOM doses. Mild, moderate and severe dysplastic cells were observed in colonic mucosa starting 8 weeks post-AOM injection. There was no statistically significant difference between number of severe dysplastic cells between the two AOM doses.

 

Conclusion: Administration of AOM 15 mg/kg BW SC is able to induce CRC in male Wistar rats. Higher dose is not necessary since it does not result in higher tumor incidence. This cancer model may be utilized to study chemopreventive effect of various agents in the future.


Keywords


Colorectal Cancer, Animal Model, Azoxymethane, Aberrant Crypt Foci



DOI: http://dx.doi.org/10.19166/med.v7i5.2469

Full Text:

PDF

References


Kwong LN, Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol.(2009) 656, 85-106

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2018). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed [5 January 2020].

Johnson RL and Fleet JC. Animal models of colorectal cancer. Cancer Metastasis Rev. (2013)32(0): 39–61.

Perše M, Cerar A. Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol. 2011; 2011:473964.

Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, Shinozaki H. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis. 2001 Nov;22(11):1871-1875.

Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2009 Jan;30(1):88-92.

Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, et al. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis. (2005) 26:229–238.

Nakagama H, Nakanishi M, Ochiai M. Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP. Cancer Sci. (2005) 96:627–636.

Andreassen A, Vikse R, Mikalsen A, Adamovic T, Steffensen IL, Hjertholm H, Levan G, Alexander J. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation. Mutat Res. (2006) 604 (1-2):60–70.

Jucá MJ, Bandeira BC, Carvalho DS, and Leal AT. Comparative study of 1,2-dimethylhydrazine and azoxymethane on the induction of colorectal cancer in rats. Journal of Coloproctology (Rio de Janeiro), (2014). 34(3), 167-173.

Christudoss P, Selvakumar R, Pulimood AB, Fleming JJ, Mathew G. Zinc and zinc related enzymes in precancerous and cancerous tissue in the colon of dimethyl hydrazine treated rats. Asian Pac J Cancer Prev. (2012) 13(2):487-492.

Kim JM, Park E. Coenzyme Q10 attenuated DMH-induced precancerous lesions in SD rats. J Nutr Sci Vitaminol (Tokyo). 2010;56(2):139-144.

Aroch I, Kraus S, Naumov I, Ron E, Shapira S, et al Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats. Therap Adv Gastroenterol. 2010 Sep;3(5):281-289.

DE-Souza ASC, Costa-Casagrande TA. Animal Models for Colorectal Cancer. Arq Bras Cir Dig. 2018; 31(2): e1369. doi: 10.1590/0102-672020180001e1369.

American Veterinary Medical Association. American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals: 2013 Edition. Version 2013.0.1. ISBN 978-1-882691-21-0.

Lu, Q., Jiang, B., Lin, C. et al. Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat. J Exp Clin Cancer Res (2008) 27, 26.

Jia Y, Xu G, Zhou W, Wang Z, Meng L, et al. (2014) Diabetes Promotes DMH-Induced Colorectal Cancer by Increasing the Activity of Glycolytic Enzymes in Rats. PLoS ONE 9(10): e110455.

Paulsen JE, Løberg EM, Olstørn HB, Knutsen H, Steffensen IL, Alexander J. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res. 2005 Jan 1;65(1):121-9.

Chen J and Huang XF. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biology & Therapy (2009), 8:14, 1313-1317,

Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, et al. Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer (2010) 102, 1555 – 1577

Cheng L and Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003 Dec 15; 9(12): 2642–2649

Zhao Y, Hasjim J, Li L, Jane JL, Hendrich S, Birt DF. Inhibition of azoxymethane-induced preneoplastic lesions in the rat colon by a cooked stearic acid complexed high-amylose cornstarch. J Agric Food Chem. 2011 Sep 14;59(17):9700-8

Martina Perše and Anton Cerar. The dimethylhydrazine induced colorectal tumours in rat - experimental colorectal carcinogenesis. Radiol Oncol 2005; 39(1): 61-70.

Željka Večerić and Anton Cerar. Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors. Radiol Oncol 2004; 38(3): 227-34.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Riska Taufik, Abidin Pandianta, Rinaldy Kusuma, Imelda L. Winoto, Ivet Suriapranata, George Mathew

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

Creative Commons License

MEDICINUS is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Copyright © Fakultas Kedokteran | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811 . All rights reserved. p-ISSN 1978-3094 | e-ISSN 2622-6995